Posts

Astellas Secures $1.34B Licensing Deal for CLDN18.2-Targeted ADC with Evopoint Biosciences

on

Sanofi, Regeneron's IL-33 Drug Fails One of Two COPD Studies, Casting Doubt on FDA Approval Timeline

on

Analysts Downplay Intellia Adverse Event, but Gene Therapy Safety Remains Under Scrutiny

on

Keros Therapeutics Halts Pulmonary Hypertension Drug After Safety Issues, Cuts 45% of Workforce

on

Sanofi, Regeneron's IL-33 Drug Fails One of Two COPD Studies, Casting Doubt on FDA Approval Timeline

on

Analysts Downplay Intellia Adverse Event, but Gene Therapy Safety Remains Under Scrutiny

on

Keros Therapeutics Halts Pulmonary Hypertension Drug After Safety Issues, Cuts 45% of Workforce

on

Merck, Daiichi Sankyo Withdraw FDA Application for HER3-Targeting ADC After Survival Endpoint Miss

on

FDA Rejects Stealth BioTherapeutics' Rare Disease Drug but Leaves Door Open for Accelerated Approval

on

Trump Administration Cancels Major Federal Funding for Moderna's Bird Flu Vaccine

on

iTeos to Shut Down Operations After TIGIT Therapy Setback

on

A New Dawn for Psychedelics: Compass Pathways Nears Major Phase 3 Psilocybin Results

on

GSK, Spero Report Major Phase 3 Win for UTI Antibiotic; Spero's Stock Surges

on

Uncertainty Surrounds Moderna's Next-Generation COVID Shot Amid Policy Changes

on

RFK Jr. Ends CDC Covid Vaccine Recommendations for Healthy Children and Pregnant Women

on

Recent Developments in NLP and Generative AI for Life Sciences and Precision Medicine (2025)

on

InflaRx Halts Rare Skin Disease Study for Vilobelimab After Futility Signal

on

Fierce Biotech Fundraising Tracker '25: Grin Raises $140M Series D and Strikes Major Angelini Deal; Syndeio Secures $90M

on

Patient Death in Rocket Pharmaceuticals Gene Therapy Trial Prompts FDA Clinical Hold

on

Sernova Chair Resigns After Insider Trading Indictment Tied to Novartis-Chinook Deal

on

Trump Taps Dr. Oz as Lead Negotiator for 'Most Favored Nation' Drug Pricing Policy

on

GlycoEra Raises $130M to Advance Protein Degraders Toward Clinic

on

Boundless Bio Lays Off 33% of Staff Following Stumble of Lead Program

on

Prothena Halts Drug and Plans Major Layoffs After Second Rare Disease Trial Failure

on

About 5% of CBER and CDER Left After FDA Staff Cuts, Analysis Finds

on

Merus Phase 2 Data: Analysts See Strong Survival in Head & Neck Cancer, 'Home Run' Hopes Emerge

on

Sanofi Acquires Vigil Neuroscience for $470 Million, Bolstering Alzheimer's Drug Pipeline

on

Jazz Releases Full Survival Data for Zepzelca in Lung Cancer at ASCO 2025

on

GLP-1s May Lower Cancer Risk; Gyre Stock Drops After Hep B Data, Share Offering

on

Korro Bio Lays Off 20% of Workforce to Extend Runway for Genetic Medicine Trials and Novo Nordisk Partnership

on

Will Trump's Tax Bill Cut Medicare by $490 Billion? Not Exactly.

on

Sanofi Opens $130M 'Flagship' US Office Facility in Morristown, New Jersey

on

Exit Strategy: Biopharma Professionals Consider Opportunities Outside Industry and US

on

HHS: All Branded Drugs Without Generic or Biosimilar Competition Must Abide by MFN Order Across All Markets

on

Spotlight on LGBTQ+ Leaders Driving Change in Life Sciences

on

FDA Expects 'Timely Availability' of Covid Shots as Advisors Update Formula Recommendation

on

Eikon Therapeutics Implements Second Major Staff Reduction in Under Two Years

on

FDA Advisory Committee Unanimously Votes Against Expanding Pfizer's Prostate Cancer Drug Combo

on

Post-Hoc: AI bio needs to heed the overhyped history of CRISPR

on

Pharma Companies Eye 'First Sale' Rule to Lessen Tariff Costs Amid New US Trade Measures

on

Moderna Shares Fall as Company Withdraws Flu/COVID-19 Combination Vaccine Application

on

FDA Advisory Committee Narrowly Votes Against UroGen's Bladder Cancer Drug, Calls for Further Studies

on

FDA Institutes Stricter, Targeted COVID Vaccine Policy, Moving Away from 'One-Size-Fits-All' Approach

on

'Go ahead and do it': Top RFK Jr. Deputy Dares Drugmakers Over Threats to Pull Manufacturing Amid Price Pressure

on

FDA Advisory Committee Splits Votes on Genentech and J&J Cancer Drugs

on